AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Medical Devices, Pharma & Biotech BS: AbbVie (HUMIRA) (humira.com)
A high-substance pharmaceutical site that prioritizes clinical data and regulatory safety disclosures over marketing hyperbole. The low BS score reflects the heavy oversight and requirement for forensic proof inherent in the pharmaceutical industry.
Fix the empty H1 tag on the homepage to clearly state the brand and primary indication for better SEO and accessibility. Implement Organization and Person schema to formally link AbbVie and medical leadership to the website’s claims. Consolidate the navigation-based ‘Leaving AbbVie’ H2 tags into a single modal to clean up the heading hierarchy. Update copyright and study dates to 2025 or 2026 to avoid the ‘aging’ content penalty as current data approaches the 36-month stale threshold.
The site exhibits high substance density, particularly in the body sections detailing trial outcomes like the 36% remission rate in Crohn’s patients. While the hero text ‘Reimagine Possible’ is a value prop cliché, it is immediately followed by specific nouns and indications. Power words are largely absent from the H3 markers, which are used strictly for functional safety warnings like ‘IMPORTANT SAFETY INFORMATION.’ Specific technical metrics, such as the 40 mg every other week dosing protocols, provide substantial evidence for the medication’s application and move the site far beyond marketing fluff.
When chunking fails, embeddings degrade, retrieval collapses, and your content loses every competitive comparison. Generate your Semantic HTML Audit to quantify the structural friction that blocks AI comprehension.
The homepage promises information about a biologic medication across several indications like Rheumatoid Arthritis and Crohn’s, and the sub-pages maintain perfect alignment. Sub-pages for Rheumatoid Arthritis and Psoriasis provide specific dosing protocols and exact trial outcomes, such as the 63% improvement rate in RA patients. There is no disconnect between the brand promise and the technical data provided on deep pages. The site successfully transitions from high-level condition overviews to granular technical specifications without shifting target audiences or value propositions.
Stop the ROI leak caused by technical debt and strategic misalignment. Conduct an Independent Strategic Diagnosis for 1 Euro to identify high impact issues across all audit categories.
The site avoids all trust theatre patterns by displaying a review_count of 0 and focusing exclusively on clinical evidence. Performance claims are backed by proof_links_count of 2 on sub-pages, leading to full prescribing information and FDA medication guides. The use of ‘Reference 1’ in headings anchors clinical claims to specific package inserts, providing a clear proof path that is verifiable by healthcare professionals.
The proof density is exceptional, with a high ratio of verifiable clinical data to unsubstantiated marketing assertions. On the Crohn’s page, specific remission rates (36% vs 12%) and symptom relief percentages (58% vs 34%) provide granular, dated evidence. Every performance claim is tied to the primary reference of the HUMIRA package insert, establishing a transparent and forensic evidence base.
To examine how structural entropy affects chunking and retrieval, review the Moz Semantic HTML audit. View the Moz Semantic HTML Audit for a complete example of heading logic, landmark integrity, and DOM depth diagnostics.
The site relies on a standard pharmaceutical template that prioritizes mandatory legal disclaimers and safety information. Matches for industry jargon include technical deliverables like ‘biologic medication’ and ‘clinical trial data,’ which are used in a substantive context. The value proposition is clearly differentiated around the specific brand entity, although the ‘What is HUMIRA?’ heading structure is a common industry template fingerprint. The repeated ‘Leaving AbbVie Web Site’ H2 blocks are generic regulatory requirements rather than unique value-add content.
Authority is primarily institutional through the AbbVie brand, but there is a notable absence of Person schema or named medical experts in the crawl. The technical implementation is slightly degraded by a missing H1 on the homepage and repetitive H2 tags for external link disclaimers. The schema_json being null suggests a missed opportunity to leverage structured data to verify the organization’s expertise and digital footprint.
Performance claims are highly regulated and substantiated by numerical trial data, preventing any marketing disconnect. For instance, the site claims more people saw 20% improvement in RA at 6 months and backs this with a specific chart reference. The site uses appropriate cautionary language, stating that ‘individual results may vary’ and providing comprehensive safety data alongside efficacy claims.
Medical Devices, Pharma & Biotech BS: AbbVie (HUMIRA) (humira.com)
The site perfectly matches the Medical and Pharmaceutical category, specifically targeting biologic therapies. All content is focused on the prescription medication adalimumab and its clinical indications for chronic inflammatory conditions.
AI does not interpret your layout visually — it interprets your structure mathematically. Explore the Semantic HTML Technical Framework to understand how heading logic, boundaries, and DOM depth determine what an LLM can retrieve.
“The score of 16 is driven by the extreme density of clinical data and the total absence of trust theatre (zero review counts without verification). Points were only added due to the absence of structured data schema and technical errors in heading hierarchy like the missing H1 and repetitive disclaimer H2s. Commodity fingerprint scores were minimized because technical jargon was used for functional clinical descriptions.”